Mochi Health vs Willow: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent research·How we rank →

Willow beats Mochi Health overall, scoring 8.2/10 vs 7.7/10. Mochi Health is more affordable at $178/mo vs $299/mo. Choose Mochi Health for users who want a tech-forward platform with app-based tracki. Choose Willow for users who want comprehensive clinical support with flexibili.

A side-by-side comparison of Mochi Health and Willow covering pricing, scores, medication types, insurance, and more to help you decide.

Mochi Health

#20 of 48

7.7/10

Tech-forward GLP-1 platform with a sleek app for tracking progress, medications, and provider communications.

Visit Mochi Health

Higher Rated

Willow

#8 of 48

8.2/10

Personalized GLP-1 weight loss with ongoing clinical support. Compounded semaglutide and tirzepatide only — Willow explicitly does not prescribe brand-name Wegovy or Zepbound. Added oral compounded semaglutide tablets as a non-injectable option.

Visit Willow

Feature	Mochi Health	Willow
Our Score	7.7/10	8.2/10
Starting Price	$178/mo	$299/mo
Medication Type	Compounded	Compounded
Insurance Accepted	No	No
Best For	Users who want a tech-forward platform with app-based tracking	Users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes
Ranking	#20	#8

Pros & Cons Compared

Mochi Health

Pros

+Flat $99/mo semaglutide at ALL dose levels — saves $100-200/mo vs competitors who charge more at higher doses
+4 semaglutide formats: injection, oral tablet, oral drops, and microdose — the most delivery options of any platform
+Registered dietitians included alongside physicians — not just medication, but nutritional support
+Both compounded and brand-name medications available (Ozempic, Wegovy, Mounjaro, Zepbound, Rybelsus)

Cons

−Separate $79/mo membership fee makes the real cost ~$178/mo for semaglutide, not the advertised $99
−No refunds for payments made over 30 days ago — limited consumer protection window
−Relatively new company (founded 2022) with less track record than established platforms

Willow

Pros

+Includes monthly provider check-ins and dose adjustments at no extra cost
+Offers both injectable AND oral compounded semaglutide — one of few platforms with a daily oral tablet option
+$299/mo all-in for compounded semaglutide with monthly provider support
+90%+ patient retention rate after 3 months per their published outcomes data

Cons

−Compounded-only — no brand-name Wegovy or Zepbound through the platform
−Tirzepatide pricing reaches $499-$524 at higher doses — starting dose is $399/mo
−Cash-pay only — no insurance billing, though they provide superbills for FSA/HSA
−Founded in 2024 — less track record than Ro or Hims, though growth has been fast

Our Verdict

Willow edges out Mochi Health with a score of 8.2/10 vs 7.7/10. If budget is your priority, Mochi Health starts at $178/mo compared to Willow's $299/mo. Choose Mochi Health if you want: users who want a tech-forward platform with app-based tracking. Choose Willow if you want: users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes.

Still undecided? Editor's #1 Overall Pick

Eden Health GLP-1

$249/mo · 8.9/10 · Both

If neither Mochi Health nor Willow feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Eden Health GLP-1 — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Eden Health GLP-1→Read our full Eden Health GLP-1 review